Pear Therapeutics' Series B Round

Pear Therapeutics raised a round of funding on January 02, 2018.

Pear Therapeutics' patented eFormulation approach combines mobile health apps with supplements, medical foods, and pharmaceuticals, to create more efficacious treatment solutions. eFormulations are si…

Articles about Pear Therapeutics' Series B Round: